Charmacy Pharmaceutical Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 29, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	626	1,058	1,400	744	603	588
Market Cap Growth	-38.49%	-24.38%	88.10%	23.48%	2.57%	-26.88%
Enterprise Value	1,376	1,681	1,659	1,548	1,675	1,021
Last Close Price	5.80	9.18	11.85	5.92	4.79	4.48
PE Ratio	11.84	18.67	24.75	7.28	21.21	12.20
Forward PE	-	13.45	13.45	13.45	13.45	13.45
PS Ratio	0.13	0.22	0.29	0.16	0.13	0.12
PB Ratio	0.97	1.61	2.13	1.11	0.97	0.98
P/TBV Ratio	1.11	1.84	2.47	1.30	1.38	1.44
P/FCF Ratio	2.32	11.01	-	18.56	-	6.26
P/OCF Ratio	2.23	9.38	-	14.94	-	3.77
EV/Sales Ratio	0.30	0.36	0.34	0.33	0.36	0.22
EV/EBITDA Ratio	7.83	10.15	11.59	11.32	13.18	7.83
EV/EBIT Ratio	9.58	11.69	13.91	14.65	18.33	9.76
EV/FCF Ratio	5.09	17.50	-	38.62	-	10.87
Debt / Equity Ratio	2.04	2.28	2.30	1.99	2.63	2.50
Debt / EBITDA Ratio	7.52	8.54	10.20	9.55	12.47	11.14
Debt / FCF Ratio	4.89	15.61	-	33.43	-	15.86
Net Debt / Equity Ratio	1.16	1.35	1.22	1.15	1.36	1.30
Net Debt / EBITDA Ratio	4.55	5.37	5.62	5.63	6.62	5.94
Net Debt / FCF Ratio	2.77	9.25	-5.31	19.22	-15.37	8.25
Asset Turnover	1.25	1.32	1.44	1.48	1.36	1.51
Inventory Turnover	5.17	5.75	6.04	7.13	6.51	6.83
Quick Ratio	0.64	0.66	0.63	0.66	0.66	0.65
Current Ratio	1.09	1.09	1.07	1.09	1.04	1.04
Return on Equity (ROE)	8.15%	8.76%	8.61%	16.46%	4.60%	8.22%
Return on Assets (ROA)	2.42%	2.52%	2.21%	2.08%	1.67%	2.08%
Return on Invested Capital (ROIC)	7.64%	7.27%	6.33%	5.62%	4.46%	5.86%
Return on Capital Employed (ROCE)	19.70%	20.20%	17.20%	15.30%	12.30%	13.80%
Earnings Yield	8.45%	5.36%	4.04%	13.74%	4.72%	8.20%
FCF Yield	43.17%	9.08%	-10.81%	5.39%	-9.08%	15.99%
Dividend Yield	8.43%	5.22%	2.79%	8.60%	-	5.30%
Payout Ratio	135.85%	120.49%	147.05%	31.44%	226.73%	139.34%
Buyback Yield / Dilution	-0.01%	0.01%	-0.00%	-0.01%	0.01%	-0.01%
Total Shareholder Return	8.43%	5.23%	2.79%	8.59%	0.01%	5.29%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.